Peptide Deep Dives

BPC-157 vs TB-500 - what is the difference?

Updated 2026-05-03

Both help tissue heal, but they work in different ways. BPC-157 promotes new blood vessel growth and helps fibroblasts (the cells that build connective tissue) repair tendons, ligaments, and gut lining. TB-500 controls actin, the building block of cell movement, which lets repair cells migrate to the injury site. People often stack them - the Wolverine Stack - because the mechanisms cover different parts of healing. BPC-157 has more human pilot data; TB-500 human data is very thin.

IfIf you have a fresh tendon or ligament injury

Thenthen BPC-157 is the more studied of the two for connective-tissue repair, though any decision about using it belongs with your provider

IfIf you are dealing with a chronic injury that is stalled

Thenthen the BPC-157 + TB-500 combination is the pairing known as the Wolverine Stack, so talk it through with your provider before combining peptides

IfIf you have a personal or family history of cancer

Thenthen talk with a physician first, since both peptides upregulate growth and angiogenesis pathways

IfIf you are wondering how you would actually use either one

Thenthen that is exactly the kind of thing to plan with a licensed provider, who can advise whether either peptide is appropriate and how it would be administered

Key facts

BPC-157 is a 15-amino-acid fragment of a stomach protective protein
TB-500 is the active fragment of Thymosin Beta-4, a 43-amino-acid actin-sequestering protein
BPC-157 acts via the FAK-paxillin pathway to drive fibroblast migration and collagen synthesis
TB-500 binds G-actin in a 1:1 ratio and activates the ILK and Akt signaling pathways
Only three small human pilot studies have examined BPC-157 - in knee pain, interstitial cystitis, and IV safety
TB-500 human data is even thinner; most evidence is preclinical (animal studies only)
In animal models, BPC-157 accelerates tendon fibroblast outgrowth up to 2.3-fold at 2 mcg/mL

Sources

PEER REVIEWED

Regeneration or Risk - BPC-157 narrative review (Curr Rev Musculoskelet Med 2025)

PEER REVIEWED

BPC-157 promotes tendon outgrowth via FAK-paxillin pathway (J Appl Physiol 2011)

PEER REVIEWED

BPC-157 in tissue repair and pain management (Int J Mol Sci 2026)

Get more like this

Your guided peptide companion.

PRTCL walks beginners through their first peptide with confidence - guided reconstitution, syringe unit math from your own numbers, vial tracking, and answers to questions like this one. Built for first-timers, useful for everyone.

· Guided walkthrough for your first dose
· Your vial and your dose, converted into syringe units
· Vial inventory and dose log tracking
· A library where every claim cites its source

Free to start.

PRTCL is educational. Always talk to a licensed provider about your situation.

Privacy Terms Home